Publications
Detailed Information
Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Yoon-La | - |
dc.contributor.author | Oh, Ensel | - |
dc.contributor.author | Park, Sarah | - |
dc.contributor.author | Kim, Yeonju | - |
dc.contributor.author | Song, Kyoung | - |
dc.contributor.author | Hong, Yun-Chul | - |
dc.contributor.author | Lee, Jeong Eon | - |
dc.contributor.author | Nam, Seok Jin | - |
dc.contributor.author | Yang, Jung-Hyun | - |
dc.contributor.author | Shin, Young Kee | - |
dc.contributor.author | Im, Young-Hyuck | - |
dc.contributor.author | Kim, Jung Han | - |
dc.contributor.author | Choi, Jong Sun | - |
dc.contributor.author | Cho, Eun Yoon | - |
dc.contributor.author | Park, Yeon-Hee | - |
dc.date.accessioned | 2012-06-27T05:16:27Z | - |
dc.date.available | 2012-06-27T05:16:27Z | - |
dc.date.issued | 2010-09-23 | - |
dc.identifier.citation | BMC CANCER; Vol.10 ;507 | ko_KR |
dc.identifier.issn | 1471-2407 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77572 | - |
dc.description.abstract | Background: Triple-negative breast cancers (TNBCs) and basal-like breast cancers (BLBCs) are known as poor outcome subtypes with a lack of targeted therapy. Previous studies have shown conflicting results regarding the difference of prognostic significance between TNBCs and BLBCs. In this study, we aimed to characterize the prognostic features of TNBCs, in view of BLBCs and quintuple-negative breast cancers (QNBC/5NPs). Methods: Using tissue microarray-based immunohistochemical analysis, we categorized 951 primary breast cancers into four or five subtypes according to the expression of ER, PR, HER2, and basal markers (CK5/6, EGFR). Results: The results of this study showed that both TNBCs and BLBCs were associated with high histological and/or nuclear grades. When the TNBCs are divided into two subtypes by the presence of basal markers, the clinicopathologic characteristics of TNBCs were mainly maintained in the BLBCs. The 5-subgrouping was the better prediction model for both disease free and overall survival in breast cancers than the 4-subgrouping. After multivariate analysis of TNBCs, the BLBCs did not have a worse prognosis than the QNBC/5NPs. Interestingly, the patients with BLBCs showed significant adjuvant chemotherapy benefit. In addition, QNBC/5NPs comprised about 6 similar to 8% of breast cancers in publicly available breast cancer datasets Conclusion: The QNBC/5NP subtype is a worse prognostic subgroup of TNBCs, especially in higher stage and this result may be related to adjuvant chemotherapy benefit of BLBCs, calling for caution in the identification of subgroups of patients for therapeutic classification. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BIOMED CENTRAL LTD | ko_KR |
dc.title | Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 최윤라 | - |
dc.contributor.AlternativeAuthor | 박사라 | - |
dc.contributor.AlternativeAuthor | 김연주 | - |
dc.contributor.AlternativeAuthor | 박연희 | - |
dc.contributor.AlternativeAuthor | 송경 | - |
dc.contributor.AlternativeAuthor | 조은윤 | - |
dc.contributor.AlternativeAuthor | 홍윤철 | - |
dc.contributor.AlternativeAuthor | 최종선 | - |
dc.contributor.AlternativeAuthor | 이정언 | - |
dc.contributor.AlternativeAuthor | 김정한 | - |
dc.contributor.AlternativeAuthor | 남석진 | - |
dc.contributor.AlternativeAuthor | 임영혁 | - |
dc.contributor.AlternativeAuthor | 양정현 | - |
dc.contributor.AlternativeAuthor | 신영기 | - |
dc.identifier.doi | 10.1186/1471-2407-10-507 | - |
dc.citation.journaltitle | BMC CANCER | - |
dc.description.citedreference | Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132 | - |
dc.description.citedreference | Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034 | - |
dc.description.citedreference | Rhee JY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-307 | - |
dc.description.citedreference | Nishimura R, 2008, BREAST CANCER-TOKYO, V15, P303, DOI 10.1007/s12282-008-0042-3 | - |
dc.description.citedreference | Tan DSP, 2008, BREAST CANCER RES TR, V111, P27, DOI 10.1007/s10549-007-9756-8 | - |
dc.description.citedreference | Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518 | - |
dc.description.citedreference | Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748 | - |
dc.description.citedreference | Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658 | - |
dc.description.citedreference | Rakha E, 2008, CLIN CANCER RES, V14, P618, DOI 10.1158/1078-0432.CCR-07-1943 | - |
dc.description.citedreference | Conforti R, 2007, ANN ONCOL, V18, P1477, DOI 10.1093/annonc/mdm209 | - |
dc.description.citedreference | Fadare O, 2007, ADV ANAT PATHOL, V14, P358 | - |
dc.description.citedreference | Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134 | - |
dc.description.citedreference | Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109 | - |
dc.description.citedreference | Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771 | - |
dc.description.citedreference | Rakha EA, 2007, CANCER, V109, P25, DOI 10.1002/cncr.22381 | - |
dc.description.citedreference | Kim MJ, 2006, HUM PATHOL, V37, P1217, DOI 10.1016/j.humpath.2006.04.015 | - |
dc.description.citedreference | Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492 | - |
dc.description.citedreference | Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421 | - |
dc.description.citedreference | Wang YX, 2005, LANCET, V365, P671 | - |
dc.description.citedreference | Nielsen TO, 2004, CLIN CANCER RES, V10, P5367 | - |
dc.description.citedreference | Rosen DG, 2004, MODERN PATHOL, V17, P790, DOI 10.1038/modpathol.3800120 | - |
dc.description.citedreference | Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972 | - |
dc.description.citedreference | Ahn SH, 2004, ARCH SURG-CHICAGO, V139, P27 | - |
dc.description.citedreference | Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100 | - |
dc.description.citedreference | van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999 | - |
dc.description.citedreference | VANTVEER, 2002, NATURE, V415, P530 | - |
dc.description.citedreference | Harvey JM, 1999, J CLIN ONCOL, V17, P1474 | - |
dc.description.citedreference | SILVER DP, J CLIN ONCOL, V28, P1145 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.